<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335015</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-6382</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>04</Day></PubDate></JournalIssue><Title>Antibiotics (Basel, Switzerland)</Title><ISOAbbreviation>Antibiotics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Incidence and Predictors of Healthcare-Associated Infections in Patients Admitted to a Temporary Intensive Care Unit during the COVID-19 Pandemic Waves: A Two-Year (2021-2023) Retrospective Cohort Study in Rome, Italy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">842</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antibiotics13090842</ELocationID><Abstract><AbstractText>To manage the number of critical COVID-19 patients, Umberto I Teaching Hospital in Rome established a temporary ICU on March 1, 2021. This study investigated the incidence and risk factors of healthcare-associated infections (HAIs) among these patients during various COVID-19 waves. Patients were grouped by admission date according to the dominant SARS-CoV-2 variant prevalent at the time (Alpha, Delta, Omicron BA.1, Omicron BA.2, Omicron BA.5, and Omicron XBB). First-HAI and mortality rates were calculated per 1000 patient-days. Predictors of first-HAI occurrence were investigated using a multivariable Fine-Gray regression model considering death as a competing event. Among 355 admitted patients, 27.3% experienced at least one HAI, and 49.6% died. Patient characteristics varied over time, with older and more complex cases in the later phases, while HAI and mortality rates were higher in the first year. Pathogens responsible for HAIs varied over time, with first <i>Acinetobacter baumannii</i> and then <i>Klebsiella pneumoniae</i> being progressively predominant. Multivariable analysis confirmed that, compared to Alpha, admission during the Omicron BA.1, BA.2, BA.5, and XBB periods was associated with lower hazards of HAI. Despite worsening COVID-19 patient conditions, late-phase HAI rates decreased, likely due to evolving pathogen characteristics, improved immunity, but also better clinical management, and adherence to infection prevention practices. Enhanced HAI prevention in emergency situations is crucial.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sciurti</LastName><ForeName>Antonio</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0001-3140-7343</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baccolini</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-7873-7817</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceparano</LastName><ForeName>Mariateresa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isonne</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-1002-9133</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Migliara</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, Health, and Health Professions, Link Campus University, 00165 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iera</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Management and Health Laboratory, Institute of Management, Department EMbeDS, Sant'Anna School of Advanced Studies, 56127 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alessandri</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-3989-4964</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Umberto I Teaching Hospital, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceccarelli</LastName><ForeName>Giancarlo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5921-3180</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marzuillo</LastName><ForeName>Carolina</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-7299-5727</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tellan</LastName><ForeName>Guglielmo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-4129-3300</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Umberto I Teaching Hospital, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Giusti</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8076-1250</Identifier><AffiliationInfo><Affiliation>Department of Anaesthesia and Intensive Care Medicine, Umberto I Teaching Hospital, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General and Specialist Surgery "P. Stefanini", Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villari</LastName><ForeName>Paolo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>The Collaborating Group</LastName><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibiotics (Basel)</MedlineTA><NlmUniqueID>101637404</NlmUniqueID><ISSNLinking>2079-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acinetobacter baumannii</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">healthcare-associated infections</Keyword><Keyword MajorTopicYN="N">infection prevention and control</Keyword></KeywordList><CoiStatement>The authors declare that they have no conflicts of interests or other interests that might be perceived to influence the results and/or discussion reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335015</ArticleId><ArticleId IdType="pmc">PMC11428387</ArticleId><ArticleId IdType="doi">10.3390/antibiotics13090842</ArticleId><ArticleId IdType="pii">antibiotics13090842</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tonetti T., Grasselli G., Zanella A., Pizzilli G., Fumagalli R., Piva S., Lorini L., Iotti G., Foti G., Colombo S., et al. Use of Critical Care Resources during the First 2 Weeks (February 24–March 8, 2020) of the COVID-19 Outbreak in Italy. Ann. Intensive Care. 2020;10:133. doi: 10.1186/s13613-020-00750-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13613-020-00750-z</ArticleId><ArticleId IdType="pmc">PMC7549086</ArticleId><ArticleId IdType="pubmed">33044646</ArticleId></ArticleIdList></Reference><Reference><Citation>Mannucci E., Silverii G.A., Monami M. Saturation of Critical Care Capacity and Mortality in Patients with the Novel Coronavirus (COVID-19) in Italy. Trends Anaesth. Crit. Care. 2020;33:33–34. doi: 10.1016/j.tacc.2020.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tacc.2020.05.002</ArticleId><ArticleId IdType="pmc">PMC7244438</ArticleId><ArticleId IdType="pubmed">38620165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministero della Salute . Circolare Del Ministero Della Salute, Incremento Disponibilità Posti Letto de Servizio Sanitario Nazionale e Ulteriori Indicazioni Relative Alla Gestione Dell’emergenza COVID-19. Ministero Della Salute; Roma, Italy: 2020.</Citation></Reference><Reference><Citation>Oakley C., Pascoe C., Balthazor D., Bennett D., Gautam N., Isaac J., Isherwood P., Matthews T., Murphy N., Oelofse T., et al. Assembly Line ICU: What the Long Shops Taught Us about Managing Surge Capacity for COVID-19. BMJ Open Qual. 2020;9:e001117. doi: 10.1136/bmjoq-2020-001117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjoq-2020-001117</ArticleId><ArticleId IdType="pmc">PMC7722360</ArticleId><ArticleId IdType="pubmed">33277292</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M., Qian Z., Zhang L. Care for Critical Ill Patients With COVID-19: Establishment of a Temporary Intensive Care Unit in an Isolated Hospital. Front. Med. 2020;7:519. doi: 10.3389/fmed.2020.00519.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00519</ArticleId><ArticleId IdType="pmc">PMC7431884</ArticleId><ArticleId IdType="pubmed">32850928</ArticleId></ArticleIdList></Reference><Reference><Citation>Zappella N., Dirani C., Lortat Jacob B., Tanaka S., Kantor E., El Kalai A., Rkik Y., Gouel Cheron A., Tran Dinh A., Montravers P. Temporary ICUs during the COVID-19 Pandemic First Wave: Description of the Cohort at a French Centre. BMC Anesthesiol. 2022;22:310. doi: 10.1186/s12871-022-01845-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12871-022-01845-9</ArticleId><ArticleId IdType="pmc">PMC9527134</ArticleId><ArticleId IdType="pubmed">36192702</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez J.V., Olivas-Martinez A., Rios-Olais F.A., Ayala-Aguillón F., Gil-López F., Leal-Villarreal M.A.d.J., Rodríguez-Crespo J.J., Jasso-Molina J.C., Enamorado-Cerna L., Dardón-Fierro F.E., et al. Outcomes in Temporary ICUs Versus Conventional ICUs: An Observational Cohort of Mechanically Ventilated Patients with COVID-19-Induced Acute Respiratory Distress Syndrome. Crit. Care Explor. 2022;4:e0668. doi: 10.1097/CCE.0000000000000668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000668</ArticleId><ArticleId IdType="pmc">PMC8963854</ArticleId><ArticleId IdType="pubmed">35372841</ArticleId></ArticleIdList></Reference><Reference><Citation>Candel F.J., Canora J., Zapatero A., Barba R., González Del Castillo J., García-Casasola G., San-Román J., Gil-Prieto R., Barreiro P., Fragiel M., et al. Temporary Hospitals in Times of the COVID Pandemic. An Example and a Practical View. Rev. Esp. Quim. 2021;34:280–288. doi: 10.37201/req/041.2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.37201/req/041.2021</ArticleId><ArticleId IdType="pmc">PMC8329569</ArticleId><ArticleId IdType="pubmed">33752321</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossi V., Del Monaco C., Gambazza S., Santambrogio M., Binda F., Retucci M., Privitera E., Mantero M., Bottino N., Laquintana D., et al. Time to Active Sitting Position: One-Year Findings from a Temporary COVID-19 Intensive Care Unit. Respir. Med. 2022;194:106773. doi: 10.1016/j.rmed.2022.106773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2022.106773</ArticleId><ArticleId IdType="pmc">PMC8843323</ArticleId><ArticleId IdType="pubmed">35203010</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Ambooken G.C., Setlur R., Paul S.K., Kanitkar M., Singh Bhatia S., Singh Kanwar R. Challenges Faced in Establishing a Dedicated 250 Bed COVID-19 Intensive Care Unit in a Temporary Structure. Trends Anaesth. Crit. Care. 2021;36:9–16. doi: 10.1016/j.tacc.2020.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tacc.2020.10.006</ArticleId><ArticleId IdType="pmc">PMC7647395</ArticleId><ArticleId IdType="pubmed">38620737</ArticleId></ArticleIdList></Reference><Reference><Citation>Dagenais C., Kielende M., Coulibaly A., Gautier L., David P.-M., Peiffer-Smadja N., Honda A., de Araújo Oliveira S.R., Traverson L., Zinszer K., et al. Lessons Learned from Field Experiences on Hospitals’ Resilience to the COVID-19 Pandemic: A Systematic Approach. Health Syst. Reform. 2023;9:2231644. doi: 10.1080/23288604.2023.2231644.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23288604.2023.2231644</ArticleId><ArticleId IdType="pubmed">37470503</ArticleId></ArticleIdList></Reference><Reference><Citation>Vranas K.C., Golden S.E., Mathews K.S., Schutz A., Valley T.S., Duggal A., Seitz K.P., Chang S.Y., Nugent S., Slatore C.G., et al. The Influence of the COVID-19 Pandemic on ICU Organization, Care Processes, and Frontline Clinician Experiences: A Qualitative Study. Chest. 2021;160:1714–1728. doi: 10.1016/j.chest.2021.05.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.05.041</ArticleId><ArticleId IdType="pmc">PMC8164514</ArticleId><ArticleId IdType="pubmed">34062115</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiest K.M., Krewulak K.D. Space, Staff, Stuff, and System: Keys to ICU Care Organization During the COVID-19 Pandemic. Chest. 2021;160:1585–1586. doi: 10.1016/j.chest.2021.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2021.07.001</ArticleId><ArticleId IdType="pmc">PMC8566879</ArticleId><ArticleId IdType="pubmed">34743838</ArticleId></ArticleIdList></Reference><Reference><Citation>Isonne C., Baccolini V., Migliara G., Ceparano M., Alessandri F., Ceccarelli G., Tellan G., Pugliese F., De Giusti M., De Vito C., et al. Comparing the Occurrence of Healthcare-Associated Infections in Patients with and without COVID-19 Hospitalized during the Pandemic: A 16-Month Retrospective Cohort Study in a Hospital Intensive Care Unit. J. Clin. Med. 2022;11:1446. doi: 10.3390/jcm11051446.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11051446</ArticleId><ArticleId IdType="pmc">PMC8910983</ArticleId><ArticleId IdType="pubmed">35268538</ArticleId></ArticleIdList></Reference><Reference><Citation>Baccolini V., Migliara G., Isonne C., Dorelli B., Barone L.C., Giannini D., Marotta D., Marte M., Mazzalai E., Alessandri F., et al. The Impact of the COVID-19 Pandemic on Healthcare-Associated Infections in Intensive Care Unit Patients: A Retrospective Cohort Study. Antimicrob. Resist. Infect. Control. 2021;10:87. doi: 10.1186/s13756-021-00959-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-021-00959-y</ArticleId><ArticleId IdType="pmc">PMC8177262</ArticleId><ArticleId IdType="pubmed">34088341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong C.C.H., Farhanah S., Linn K.Z., Tang Y.W., Poon C.Y., Lim A.Y., Tan H.R., Binte Hamed N.H., Huan X., Puah S.H., et al. Nosocomial Infections among COVID-19 Patients: An Analysis of Intensive Care Unit Surveillance Data. Antimicrob. Resist. Infect. Control. 2021;10:119. doi: 10.1186/s13756-021-00988-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-021-00988-7</ArticleId><ArticleId IdType="pmc">PMC8358905</ArticleId><ArticleId IdType="pubmed">34384493</ArticleId></ArticleIdList></Reference><Reference><Citation>Agodi A., Barchitta M., Finazzi S., Fadda G., Fortunato Paolo D. Sorveglianza Delle ICA Nelle Unità di Terapia Intensiva.  [(accessed on 26 February 2024)].  Available online:  https://www.epicentro.iss.it/sorveglianza-ica/sorveglianza-terapia-intensiva.</Citation></Reference><Reference><Citation>Fakhreddine S., Fawaz M., Hassanein S., Al Khatib A. Prevalence and Mortality Rate of Healthcare-Associated Infections among COVID-19 Patients: A Retrospective Cohort Community-Based Approach. Front. Public. Health. 2023;11:1235636. doi: 10.3389/fpubh.2023.1235636.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1235636</ArticleId><ArticleId IdType="pmc">PMC10449454</ArticleId><ArticleId IdType="pubmed">37637822</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloch N., Rüfenacht S., Ludwinek M., Frick W., Kleger G.-R., Schneider F., Albrich W.C., Flury D., Kuster S.P., Schlegel M., et al. Healthcare-associated Infections in Intensive Care Unit Patients with and without COVID-19: A Single Center Prospective Surveillance Study. Antimicrob. Resist. Infect. Control. 2023;12:147. doi: 10.1186/s13756-023-01353-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13756-023-01353-6</ArticleId><ArticleId IdType="pmc">PMC10729473</ArticleId><ArticleId IdType="pubmed">38111021</ArticleId></ArticleIdList></Reference><Reference><Citation>Saini V., Jain C., Singh N.P., Alsulimani A., Gupta C., Dar S.A., Haque S., Das S. Paradigm Shift in Antimicrobial Resistance Pattern of Bacterial Isolates during the COVID-19 Pandemic. Antibiotics. 2021;10:954. doi: 10.3390/antibiotics10080954.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10080954</ArticleId><ArticleId IdType="pmc">PMC8388877</ArticleId><ArticleId IdType="pubmed">34439004</ArticleId></ArticleIdList></Reference><Reference><Citation>Langford B.J., So M., Simeonova M., Leung V., Lo J., Kan T., Raybardhan S., Sapin M.E., Mponponsuo K., Farrell A., et al. Antimicrobial Resistance in Patients with COVID-19: A Systematic Review and Meta-Analysis. Lancet Microbe. 2023;4:e179–e191. doi: 10.1016/S2666-5247(22)00355-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(22)00355-X</ArticleId><ArticleId IdType="pmc">PMC9889096</ArticleId><ArticleId IdType="pubmed">36736332</ArticleId></ArticleIdList></Reference><Reference><Citation>Provenzano B.C., Bartholo T., Ribeiro-Alves M., dos Santos A.P.G., Mafort T.T., de Castro M.C.S., de Oliveira J.G.P., Bruno L.P., Lopes A.J., da Costa C.H., et al. The Impact of Healthcare-Associated Infections on COVID-19 Mortality: A Cohort Study from a Brazilian Public Hospital. Rev. Assoc. Médica Bras. 2021;67:997–1002. doi: 10.1590/1806-9282.20210433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1806-9282.20210433</ArticleId><ArticleId IdType="pubmed">34817513</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezaie F., Mohammadi-Shahboulaghi F., Fadayevatan R., Shati M., Ghaedamini Harouni G. Predictors of In-ICU Mortality Among Older Patients with Healthcare-Associated Infection: A Cohort Study. J. Kermanshah Univ. Med. Sci. 2023;27:e139129. doi: 10.5812/jkums-139129.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/jkums-139129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonsignore M., Hohenstein S., Kodde C., Leiner J., Schwegmann K., Bollmann A., Möller R., Kuhlen R., Nachtigall I. Burden of Hospital-Acquired SARS-CoV-2 Infections in Germany: Occurrence and Outcomes of Different Variants. J. Hosp. Infect. 2022;129:82–88. doi: 10.1016/j.jhin.2022.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2022.08.004</ArticleId><ArticleId IdType="pmc">PMC9391075</ArticleId><ArticleId IdType="pubmed">35995339</ArticleId></ArticleIdList></Reference><Reference><Citation>Migliara G., Paolo C., Barbato D., Baccolini V., Salerno C., Nardi A. Multimodal Surveillance of Healthcare Associated Infections in an Intensive Care Unit of a Large Teaching Hospital. Ann. Ig. 2019;31:399–413.</Citation><ArticleIdList><ArticleId IdType="pubmed">31304521</ArticleId></ArticleIdList></Reference><Reference><Citation>NHSN Patient Safety Component Manual 2016.  [(accessed on 6 November 2023)]; Available online:  https://stacks.cdc.gov/view/cdc/43374.</Citation></Reference><Reference><Citation>European Surveillance of Healthcare-Associated Infections in Intensive Care Units: HAI Net ICU Protocol, Version 1.02. 2015.  [(accessed on 6 November 2023)].  Available online:  https://data.europa.eu/doi/10.2900/371526.</Citation><ArticleIdList><ArticleId IdType="doi">10.2900/371526</ArticleId></ArticleIdList></Reference><Reference><Citation>Magiorakos A.-P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1469-0691.2011.03570.x</ArticleId><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference><Reference><Citation>Shafie M.H., Antony Dass M., Ahmad Shaberi H.S., Zafarina Z. Screening and Confirmation Tests for SARS-CoV-2: Benefits and Drawbacks. Beni Suef Univ. J. Basic. Appl. Sci. 2023;12:6. doi: 10.1186/s43088-023-00342-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43088-023-00342-3</ArticleId><ArticleId IdType="pmc">PMC9833029</ArticleId><ArticleId IdType="pubmed">36647397</ArticleId></ArticleIdList></Reference><Reference><Citation>Stefanelli P., Ambrosio L., Di Martino A., Riccardo F., Petrone D., Bella A., Pezzotti P., Palamara A.T. Monitoraggio Delle Varianti del Virus SARS-CoV-2 di Interesse in Sanità Pubblica in Italia—Archivio Dei Rapporti Periodici.  [(accessed on 26 October 2023)].  Available online:  https://www.epicentro.iss.it/coronavirus/sars-cov-2-monitoraggio-varianti-rapporti-periodici.</Citation></Reference><Reference><Citation>Von Elm E., Altman D.G., Egger M., Pocock S.J., Gøtzsche P.C., Vandenbroucke J.P., for the STROBE Initiative The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies. PLoS Med. 2007;4:e296. doi: 10.1371/journal.pmed.0040296.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.0040296</ArticleId><ArticleId IdType="pmc">PMC2020495</ArticleId><ArticleId IdType="pubmed">17941714</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin P.C., Lee D.S., Fine J.P. Introduction to the Analysis of Survival Data in the Presence of Competing Risks. Circulation. 2016;133:601–609. doi: 10.1161/CIRCULATIONAHA.115.017719.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.017719</ArticleId><ArticleId IdType="pmc">PMC4741409</ArticleId><ArticleId IdType="pubmed">26858290</ArticleId></ArticleIdList></Reference><Reference><Citation>Fine J.P., Gray R.J. A Proportional Hazards Model for the Subdistribution of a Competing Risk. J. Am. Stat. Assoc. 1999;94:496–509. doi: 10.1080/01621459.1999.10474144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01621459.1999.10474144</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbot D., Massamba V.K. A Descriptive Review of Variable Selection Methods in Four Epidemiologic Journals: There Is Still Room for Improvement. Eur. J. Epidemiol. 2019;34:725–730. doi: 10.1007/s10654-019-00529-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10654-019-00529-y</ArticleId><ArticleId IdType="pubmed">31161279</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham J.W., Olchowski A.E., Gilreath T.D. How Many Imputations Are Really Needed? Some Practical Clarifications of Multiple Imputation Theory. Prev. Sci. 2007;8:206–213. doi: 10.1007/s11121-007-0070-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11121-007-0070-9</ArticleId><ArticleId IdType="pubmed">17549635</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrone D., Mateo-Urdiales A., Sacco C., Riccardo F., Bella A., Ambrosio L., Lo Presti A., Di Martino A., Ceccarelli E., Del Manso M., et al. Reduction of the Risk of Severe COVID-19 Due to Omicron Compared to Delta Variant in Italy (November 2021–February 2022) Int. J. Infect. Dis. 2023;129:135–141. doi: 10.1016/j.ijid.2023.01.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.027</ArticleId><ArticleId IdType="pmc">PMC9877142</ArticleId><ArticleId IdType="pubmed">36708869</ArticleId></ArticleIdList></Reference><Reference><Citation>Marziano V., Guzzetta G., Menegale F., Sacco C., Petrone D., Mateo Urdiales A., Del Manso M., Bella A., Fabiani M., Vescio M.F., et al. Estimating SARS-CoV-2 Infections and Associated Changes in COVID-19 Severity and Fatality. Influenza Other Respir. Viruses. 2023;17:e13181. doi: 10.1111/irv.13181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.13181</ArticleId><ArticleId IdType="pmc">PMC10432583</ArticleId><ArticleId IdType="pubmed">37599801</ArticleId></ArticleIdList></Reference><Reference><Citation>Ministero della Salute . Decreto 12 Marzo 2021, Approvazione Del Piano Strategico Nazionale Dei Vaccini per La Prevenzione Delle Infezioni Da SARS-CoV-2, Raccomandazioni Ad Interim Sui Gruppi Target Della Vaccinazione Anti SARS-CoV-2/COVID-19. Ministero della Salute; Roma, Italy: 2021.</Citation></Reference><Reference><Citation>Regione Lazio . Determinazione, Approvazione Del Piano Regionale Della Campagna Di Vaccinazione Anti SARS-CoV-2. Documento Ad Interim. Aggiornamento Febbraio 2021. Regione Lazio; Roma, Italy: 2021.</Citation></Reference><Reference><Citation>Shenai M.B., Rahme R., Noorchashm H. Equivalency of Protection From Natural Immunity in COVID-19 Recovered Versus Fully Vaccinated Persons: A Systematic Review and Pooled Analysis. Cureus. 2021;13:e19102. doi: 10.7759/cureus.19102.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.19102</ArticleId><ArticleId IdType="pmc">PMC8627252</ArticleId><ArticleId IdType="pubmed">34868754</ArticleId></ArticleIdList></Reference><Reference><Citation>Franchi M., Pellegrini G., Cereda D., Bortolan F., Leoni O., Pavesi G., Galli M., Valenti G., Corrao G. Natural and Vaccine-Induced Immunity Are Equivalent for the Protection against SARS-CoV-2 Infection. J. Infect. Public Health. 2023;16:1137–1141. doi: 10.1016/j.jiph.2023.05.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.05.018</ArticleId><ArticleId IdType="pmc">PMC10198735</ArticleId><ArticleId IdType="pubmed">37267680</ArticleId></ArticleIdList></Reference><Reference><Citation>Bobrovitz N., Ware H., Ma X., Li Z., Hosseini R., Cao C., Selemon A., Whelan M., Premji Z., Issa H., et al. Protective Effectiveness of Previous SARS-CoV-2 Infection and Hybrid Immunity against the Omicron Variant and Severe Disease: A Systematic Review and Meta-Regression. Lancet Infect. Dis. 2023;23:556–567. doi: 10.1016/S1473-3099(22)00801-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(22)00801-5</ArticleId><ArticleId IdType="pmc">PMC10014083</ArticleId><ArticleId IdType="pubmed">36681084</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong S.W.X., Chiew C.J., Ang L.W., Mak T.M., Cui L., Toh M.P.H.S., Lim Y.D., Lee P.H., Lee T.H., Chia P.Y., et al. Clinical and Virological Features of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern: A Retrospective Cohort Study Comparing B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) Clin. Infect. Dis. 2022;75:e1128–e1136. doi: 10.1093/cid/ciab721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab721</ArticleId><ArticleId IdType="pmc">PMC8522361</ArticleId><ArticleId IdType="pubmed">34423834</ArticleId></ArticleIdList></Reference><Reference><Citation>Nyberg T., Ferguson N.M., Nash S.G., Webster H.H., Flaxman S., Andrews N., Hinsley W., Bernal J.L., Kall M., Bhatt S., et al. Comparative Analysis of the Risks of Hospitalisation and Death Associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) Variants in England: A Cohort Study. Lancet. 2022;399:1303–1312. doi: 10.1016/S0140-6736(22)00462-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00462-7</ArticleId><ArticleId IdType="pmc">PMC8926413</ArticleId><ArticleId IdType="pubmed">35305296</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouzid D., Visseaux B., Kassasseya C., Daoud A., Fémy F., Hermand C., Truchot J., Beaune S., Javaud N., Peyrony O., et al. Comparison of Patients Infected With Delta Versus Omicron COVID-19 Variants Presenting to Paris Emergency Departments: A Retrospective Cohort Study. Ann. Intern. Med. 2022;175:831–837. doi: 10.7326/M22-0308.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M22-0308</ArticleId><ArticleId IdType="pmc">PMC8941485</ArticleId><ArticleId IdType="pubmed">35286147</ArticleId></ArticleIdList></Reference><Reference><Citation>Brehm T.T., Heyer A., Woo M.S., Fischer M., van der Meirschen M., Wichmann D., Jarczak D., Roedl K., Schmiedel S., Addo M.M., et al. Comparative Analysis of Characteristics and Outcomes in Hospitalized COVID-19 Patients Infected with Different SARS-CoV-2 Variants between January 2020 and April 2022—A Retrospective Single-Center Cohort Study. J. Infect. Public Health. 2023;16:1806–1812. doi: 10.1016/j.jiph.2023.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.08.010</ArticleId><ArticleId IdType="pubmed">37741015</ArticleId></ArticleIdList></Reference><Reference><Citation>Noureddine F.Y., Chakkour M., El Roz A., Reda J., Al Sahily R., Assi A., Joma M., Salami H., Hashem S.J., Harb B., et al. The Emergence of SARS-CoV-2 Variant(s) and Its Impact on the Prevalence of COVID-19 Cases in the Nabatieh Region, Lebanon. Med. Sci. 2021;9:40. doi: 10.3390/medsci9020040.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medsci9020040</ArticleId><ArticleId IdType="pmc">PMC8293406</ArticleId><ArticleId IdType="pubmed">34199617</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Liu B., Zhang S., Huang N., Zhao T., Lu Q.-B., Cui F. Differences in Incidence and Fatality of COVID-19 by SARS-CoV-2 Omicron Variant versus Delta Variant in Relation to Vaccine Coverage: A World-Wide Review. J. Med. Virol. 2023;95:e28118. doi: 10.1002/jmv.28118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.28118</ArticleId><ArticleId IdType="pmc">PMC9537802</ArticleId><ArticleId IdType="pubmed">36056540</ArticleId></ArticleIdList></Reference><Reference><Citation>ECDC . Interim Public Health Considerations for COVID-19 Vaccination Roll-Out during 2023. ECDC; Stockholm, Sweden: 2023.</Citation></Reference><Reference><Citation>ECDC . Interim Analysis of COVID-19 Vaccine Effectiveness against Hospitalisation and Death Using Electronic Health Records in Six European Countries. ECDC; Stockholm, Sweden: 2023.</Citation></Reference><Reference><Citation>Barchitta M., Maugeri A., Favara G., Riela P.M., Gallo G., Mura I., Agodi A. A Machine Learning Approach to Predict Healthcare-Associated Infections at Intensive Care Unit Admission: Findings from the SPIN-UTI Project. J. Hosp. Infect. 2021;112:77–86. doi: 10.1016/j.jhin.2021.02.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2021.02.025</ArticleId><ArticleId IdType="pubmed">33676936</ArticleId></ArticleIdList></Reference><Reference><Citation>Vicka V., Januskeviciute E., Miskinyte S., Ringaitiene D., Serpytis M., Klimasauskas A., Jancoriene L., Sipylaite J. Comparison of Mortality Risk Evaluation Tools Efficacy in Critically Ill COVID-19 Patients. BMC Infect. Dis. 2021;21:1173. doi: 10.1186/s12879-021-06866-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06866-2</ArticleId><ArticleId IdType="pmc">PMC8607225</ArticleId><ArticleId IdType="pubmed">34809594</ArticleId></ArticleIdList></Reference><Reference><Citation>Razazi K., Martins Bexiga A., Arrestier R., Peiffer B., Voiriot G., Luyt C.-E., Urbina T., Mayaux J., Pham T., Roux D., et al. SARS-CoV-2 Variants and Mutational Patterns: Relationship with Risk of Ventilator-Associated Pneumonia in Critically Ill COVID-19 Patients in the Era of Dexamethasone. Sci. Rep. 2023;13:6658. doi: 10.1038/s41598-023-33639-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-023-33639-5</ArticleId><ArticleId IdType="pmc">PMC10123590</ArticleId><ArticleId IdType="pubmed">37095145</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Therapeutics and COVID-19: Living Guideline. WHO; Geneva, Switzerland: 2023.</Citation></Reference><Reference><Citation>Koh D. Occupational Risks for COVID-19 Infection. Occup Med. 2020;70:3–5. doi: 10.1093/occmed/kqaa036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqaa036</ArticleId><ArticleId IdType="pmc">PMC7107962</ArticleId><ArticleId IdType="pubmed">32107548</ArticleId></ArticleIdList></Reference><Reference><Citation>Cawcutt K.A., Starlin R., Rupp M.E. Fighting Fear in Healthcare Workers during the COVID-19 Pandemic. Infect. Control Hosp. Epidemiol. 2020;41:1192–1193. doi: 10.1017/ice.2020.315.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.315</ArticleId><ArticleId IdType="pmc">PMC7338429</ArticleId><ArticleId IdType="pubmed">32580790</ArticleId></ArticleIdList></Reference><Reference><Citation>George J., Shafqat N., Verma R., Patidar A.B. Factors Influencing Compliance With Personal Protective Equipment (PPE) Use Among Healthcare Workers. Cureus. 2023;15:e35269. doi: 10.7759/cureus.35269.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.35269</ArticleId><ArticleId IdType="pmc">PMC10035759</ArticleId><ArticleId IdType="pubmed">36968930</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangel K., De-Simone S.G. Treatment and Management of Acinetobacter Pneumonia: Lessons Learned from Recent World Event. Infect. Drug Resist. 2024;17:507–529. doi: 10.2147/IDR.S431525.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S431525</ArticleId><ArticleId IdType="pmc">PMC10860873</ArticleId><ArticleId IdType="pubmed">38348231</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouyer M., Strazzulla A., Youbong T., Tarteret P., Pitsch A., de Pontfarcy A., Cassard B., Vignier N., Pourcine F., Jochmans S., et al. Ventilator-Associated Pneumonia in COVID-19 Patients: A Retrospective Cohort Study. Antibiotics. 2021;10:988. doi: 10.3390/antibiotics10080988.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10080988</ArticleId><ArticleId IdType="pmc">PMC8388913</ArticleId><ArticleId IdType="pubmed">34439038</ArticleId></ArticleIdList></Reference><Reference><Citation>Ippolito M., Misseri G., Catalisano G., Marino C., Ingoglia G., Alessi M., Consiglio E., Gregoretti C., Giarratano A., Cortegiani A. Ventilator-Associated Pneumonia in Patients with COVID-19: A Systematic Review and Meta-Analysis. Antibiotics. 2021;10:545. doi: 10.3390/antibiotics10050545.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics10050545</ArticleId><ArticleId IdType="pmc">PMC8150614</ArticleId><ArticleId IdType="pubmed">34067186</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickens C.O., Gao C.A., Cuttica M.J., Smith S.B., Pesce L.L., Grant R.A., Kang M., Morales-Nebreda L., Bavishi A.A., Arnold J.M., et al. Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia. Am. J. Respir. Crit. Care Med. 2021;204:921–932. doi: 10.1164/rccm.202106-1354OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202106-1354OC</ArticleId><ArticleId IdType="pmc">PMC8534629</ArticleId><ArticleId IdType="pubmed">34409924</ArticleId></ArticleIdList></Reference><Reference><Citation>François B., Laterre P.-F., Luyt C.-E., Chastre J. The Challenge of Ventilator-Associated Pneumonia Diagnosis in COVID-19 Patients. Crit. Care. 2020;24:289. doi: 10.1186/s13054-020-03013-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03013-2</ArticleId><ArticleId IdType="pmc">PMC7273812</ArticleId><ArticleId IdType="pubmed">32503590</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell B.G., Schellevis F., Stobberingh E., Goossens H., Pringle M. A Systematic Review and Meta-Analysis of the Effects of Antibiotic Consumption on Antibiotic Resistance. BMC Infect. Dis. 2014;14:13. doi: 10.1186/1471-2334-14-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-13</ArticleId><ArticleId IdType="pmc">PMC3897982</ArticleId><ArticleId IdType="pubmed">24405683</ArticleId></ArticleIdList></Reference><Reference><Citation>De Blasiis M.R., Sciurti A., Baccolini V., Isonne C., Ceparano M., Iera J., De Vito C., Marzuillo C., Villari P., Migliara G. Impact of Antibiotic Exposure on Antibiotic-Resistant Acinetobacter Baumannii Isolation in Intensive Care Unit Patients: A Systematic Review and Meta-Analysis. J. Hosp. Infect. 2024;143:123–139. doi: 10.1016/j.jhin.2023.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jhin.2023.11.002</ArticleId><ArticleId IdType="pubmed">37972711</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg S.K. Antibiotic Misuse during COVID-19 Pandemic: A Recipe for Disaster. Indian J. Crit. Care Med. 2021;25:617–619. doi: 10.5005/jp-journals-10071-23862.</Citation><ArticleIdList><ArticleId IdType="doi">10.5005/jp-journals-10071-23862</ArticleId><ArticleId IdType="pmc">PMC8286398</ArticleId><ArticleId IdType="pubmed">34316138</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaaban T., Ezzeddine Z., Ghssein G. Antibiotic Misuse during the COVID-19 Pandemic in Lebanon: A Cross-Sectional Study. COVID. 2024;4:921–929. doi: 10.3390/covid4070064.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid4070064</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC . Core Elements of Hospital Antibiotic Stewardship Programs. CDC; Atlanta, GA, USA: 2019.</Citation></Reference><Reference><Citation>Raoofi S., Pashazadeh Kan F., Rafiei S., Hosseinipalangi Z., Noorani Mejareh Z., Khani S., Abdollahi B., Seyghalani Talab F., Sanaei M., Zarabi F., et al. Global Prevalence of Nosocomial Infection: A Systematic Review and Meta-Analysis. PLoS ONE. 2023;18:e0274248. doi: 10.1371/journal.pone.0274248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274248</ArticleId><ArticleId IdType="pmc">PMC9882897</ArticleId><ArticleId IdType="pubmed">36706112</ArticleId></ArticleIdList></Reference><Reference><Citation>Babamahmoodi F., Rezai M.S., Ahangarkani F., Mohammadi Kali A., Alizadeh-Navaei R., Alishahi A., Najafi N., Haddadi A., Davoudi A., Azargon L., et al. Multiple Candida Strains Causing Oral Infection in COVID-19 Patients under Corticosteroids and Antibiotic Therapy: An Observational Study. Front. Cell Infect. Microbiol. 2022;12:1103226. doi: 10.3389/fcimb.2022.1103226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.1103226</ArticleId><ArticleId IdType="pmc">PMC9816329</ArticleId><ArticleId IdType="pubmed">36619762</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh R., Malik P., Kumar M., Kumar R., Alam M.S., Mukherjee T.K. Secondary Fungal Infections in SARS-CoV-2 Patients: Pathological Whereabouts, Cautionary Measures, and Steadfast Treatments. Pharmacol. Rep. 2023;75:817–837. doi: 10.1007/s43440-023-00506-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s43440-023-00506-z</ArticleId><ArticleId IdType="pubmed">37354313</ArticleId></ArticleIdList></Reference><Reference><Citation>Camirand-Lemyre F., Merson L., Tirupakuzhi Vijayaraghavan B.K., Burrell A.J.C., Citarella B.W., Domingue M.-P., Lévesque S., Usuf E., Wils E.-J., Ohshimo S., et al. Implementation of Recommendations on the Use of Corticosteroids in Severe COVID-19. JAMA Netw. Open. 2023;6:e2346502. doi: 10.1001/jamanetworkopen.2023.46502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.46502</ArticleId><ArticleId IdType="pmc">PMC10751594</ArticleId><ArticleId IdType="pubmed">38147336</ArticleId></ArticleIdList></Reference><Reference><Citation>Agodi A., Barchitta M., Auxilia F., Brusaferro S., D’Errico M.M., Montagna M.T., Pasquarella C., Tardivo S., Arrigoni C., Fabiani L., et al. Epidemiology of Intensive Care Unit-Acquired Sepsis in Italy: Results of the SPIN-UTI Network. Ann. Ig. 2018;30:15–21. doi: 10.7416/ai.2018.2247.</Citation><ArticleIdList><ArticleId IdType="doi">10.7416/ai.2018.2247</ArticleId><ArticleId IdType="pubmed">30374508</ArticleId></ArticleIdList></Reference><Reference><Citation>GISIO. SItI PROGETTO SPIN-UTI  Ottava Edizione 2020/2021. Sorveglianza Attiva Prospettica Delle Infezioni Nosocomiali Nelle Unità Di Terapia Intensiva (UTI). Risultati Finali 2021.  [(accessed on 26 March 2024)].  Available online:  https://www.epicentro.iss.it/infezioni-correlate/pdf/REPORT%20SPIN-UTI%202020-2021.pdf.</Citation></Reference><Reference><Citation>ECDC . Healthcare-Associated Infections Acquired in Intensive Care Units. Annual Epidemiological Report for 2020. ECDC; Stockholm, Sweden: 2024.</Citation></Reference><Reference><Citation>Fournier P.E., Richet H., Weinstein R.A. The Epidemiology and Control of Acinetobacter Baumannii in Health Care Facilities. Clin. Infect. Dis. 2006;42:692–699. doi: 10.1086/500202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/500202</ArticleId><ArticleId IdType="pubmed">16447117</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbas R., Chakkour M., Zein El Dine H., Obaseki E.F., Obeid S.T., Jezzini A., Ghssein G., Ezzeddine Z. General Overview of Klebsiella Pneumonia: Epidemiology and the Role of Siderophores in Its Pathogenicity. Biology. 2024;13:78. doi: 10.3390/biology13020078.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology13020078</ArticleId><ArticleId IdType="pmc">PMC10886558</ArticleId><ArticleId IdType="pubmed">38392297</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomczyk S., Zanichelli V., Grayson M.L., Twyman A., Abbas M., Pires D., Allegranzi B., Harbarth S. Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter Baumannii, and Pseudomonas Aeruginosa in Healthcare Facilities: A Systematic Review and Reanalysis of Quasi-Experimental Studies. Clin. Infect. Dis. 2019;68:873–884. doi: 10.1093/cid/ciy752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy752</ArticleId><ArticleId IdType="pmc">PMC6389314</ArticleId><ArticleId IdType="pubmed">30475989</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>